Another question is whether the typical melanoma patient will be willing to stay out of the sun while taking PLX4032.
Exllent point. I was shocked after reading this part.
While I consider the article overall good, I am a little bit disturbed by the emotional approach to the subject of clinical trial/drug development process rather than scientific approach. I would like to see two separate articles, one from emotional approach, one from scientific approach - as a couple of other posts pointed out already, much of this drug is still unknown. The article tried to make judgement on clinical trial/drug development process, while tried not to make judgement on individual behavior.